- Home
- GFAI vs PMN Comparison
GFAI vs PMN Comparison
Compare GFAI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- PMN
- Stock Information
- Founded
- GFAI 2018
- PMN 2004
- Country
- GFAI Singapore
- PMN Canada
- Employees
- GFAI N/A
- PMN N/A
- Industry
- GFAI Diversified Commercial Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- GFAI Consumer Discretionary
- PMN Health Care
- Exchange
- GFAI Nasdaq
- PMN Nasdaq
- Market Cap
- GFAI 20.7M
- PMN 23.9M
- IPO Year
- GFAI N/A
- PMN N/A
- Fundamental
- Price
- GFAI $1.01
- PMN $0.64
- Analyst Decision
- GFAI Strong Buy
- PMN Strong Buy
- Analyst Count
- GFAI 2
- PMN 1
- Target Price
- GFAI $6.75
- PMN $6.00
- AVG Volume (30 Days)
- GFAI 329.7K
- PMN 36.5K
- Earning Date
- GFAI 04-28-2025
- PMN 05-13-2025
- Dividend Yield
- GFAI N/A
- PMN N/A
- EPS Growth
- GFAI N/A
- PMN N/A
- EPS
- GFAI N/A
- PMN 0.11
- Revenue
- GFAI $35,841,743.00
- PMN N/A
- Revenue This Year
- GFAI $0.37
- PMN N/A
- Revenue Next Year
- GFAI $5.60
- PMN N/A
- P/E Ratio
- GFAI N/A
- PMN $5.92
- Revenue Growth
- GFAI 1.78
- PMN N/A
- 52 Week Low
- GFAI $0.76
- PMN $0.51
- 52 Week High
- GFAI $3.88
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- GFAI 48.56
- PMN 47.53
- Support Level
- GFAI $0.78
- PMN $0.51
- Resistance Level
- GFAI $1.07
- PMN $0.65
- Average True Range (ATR)
- GFAI 0.09
- PMN 0.09
- MACD
- GFAI 0.02
- PMN 0.00
- Stochastic Oscillator
- GFAI 80.65
- PMN 50.00
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.